Gilder Gagnon Howe & Co’s GoodRx Holdings GDRX Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-226,109	Closed	-$1.57M	–	265
2024 Q3	$1.57M	Sell	226,109 -678	-0.3%	-$5.32K	0.02%	194
2024 Q2	$1.77M	Buy	226,787 +2,473	+1%	+$18.3K	0.02%	185
2024 Q1	$1.59M	Buy	+224,314	New	+$1.48M	0.02%	195
2023 Q4	–	Sell	-108,061	Closed	-$608K	–	262
2023 Q3	$608K	Buy	+108,061	New	+$720K	0.01%	224
2021 Q2	–	Sell	-16,466	Closed	-$643K	–	422
2021 Q1	$643K	Buy	16,466 +486	+3%	+$21.9K	﹤0.01%	312
2020 Q4	$645K	Buy	15,980 +10,980	+220%	+$504K	﹤0.01%	281
2020 Q3	$278K	Buy	+5,000	New	+$265K	﹤0.01%	295

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $292M AUM 34.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

LCM

Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $915M AUM 2.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RRCP

Rip Road Capital Partners Boston, Massachusetts $62.5M AUM 1.22% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Gilder Gagnon Howe & Co's GDRX Position: Q4 2024 in Review

Gilder Gagnon Howe & Co sold out of GoodRx Holdings (GDRX) in Q4 2024, closing a stake of 226,109 shares — an estimated $1.57M sold.

Gilder Gagnon Howe & Co first reported a position in GDRX in Q3 2020 and held it in 7 quarters. The position peaked at $1.77M in Q2 2024. 170 funds tracked by Wall St. Rank hold GDRX as of Q4 2024.

Gilder Gagnon Howe & Co reported no remaining GoodRx Holdings position as of Q4 2024 after selling out during the quarter.
Gilder Gagnon Howe & Co sold 226,109 GoodRx Holdings shares in Q4 2024, an estimated $1.57M.
Gilder Gagnon Howe & Co first reported a position in GoodRx Holdings in Q3 2020 and held it in 7 quarters.
Gilder Gagnon Howe & Co's GoodRx Holdings position peaked at $1.77M in Q2 2024.
170 funds tracked by Wall St. Rank held GoodRx Holdings as of Q4 2024.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2024, filed 14 Feb 2025.